ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1-Hydroxybenzotriazole → 6-[(3R)-3-(tert-Butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoyl]-5-ethyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine

HRID 132885
印刷

反応式

HRID 132885 の反応式
Cl.Cl.[CH2:3]([CH:5]1[C:10]2=[N:11][CH:12]=[CH:13][N:14]=[C:9]2[CH2:8][CH2:7][NH:6]1)[CH3:4].C(N(CC)C(C)C)(C)C.[C:24]([O:28][C:29]([NH:31][C@H:32]([CH2:37][C:38]1[CH:43]=[C:42]([F:44])[C:41]([F:45])=[CH:40][C:39]=1[F:46])[CH2:33][C:34](O)=[O:35])=[O:30])([CH3:27])([CH3:26])[CH3:25].ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>CN(C)C=O>[C:24]([O:28][C:29]([NH:31][C@H:32]([CH2:37][C:38]1[CH:43]=[C:42]([F:44])[C:41]([F:45])=[CH:40][C:39]=1[F:46])[CH2:33][C:34]([N:6]1[CH2:7][CH2:8][C:9]2[C:10](=[N:11][CH:12]=[CH:13][N:14]=2)[CH:5]1[CH2:3][CH3:4])=[O:35])=[O:30])([CH3:27])([CH3:25])[CH3:26]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 7146288(R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid2 回HCID 691934695-Ethyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine dihydrochloride2 回

生成物 1

HCID 69182599
6-[(3R)-3-(tert-Butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoyl]-5-ethyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

5-Ethyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine dihydrochloride (Intermediate 32, 26 mg, 0.11 mmol) was dissolved in N,N-dimethylformamide (DMF, 0.75 mL) containing N,N-diisopropylethylamine (0.046 mL, 34 mg, 0.26 mmol). (3R)-3-(tert-Butoxycarbonylamino)4 (2,4,5-trifluorophenyl)butanoic acid (Intermediate 3, 36 mg, 0.11 mmol), 1-hydroxybenzotriazole (16 mg, 0.12 mmol), and a portion of molecular sieve pellets (4 Å) were added, followed 10 min later by 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (33 mg, 0.17 mmol). After stirring for 16 h at room temperature, the mixture was partitioned between ethyl acetate (25 mL) and saturated aqueous sodium bicarbonate solution (10 mL). The organic layer was washed with saturated aqueous brine (10 mL) and the aqueous layers were extracted in succession with ethyl acetate (25 mL). The organic layers were dried over sodium sulfate, decanted, and evaporated. Purification by flash column chromatography (silica gel, 15-20% ethyl aceate/0.75-1.0% methanol/dichloromethane) gave the title compound as a mixture of diastereomers. Separation was accomplished by EPLC using a Chiralcel OJ column, eluting with 8% ethanol in hexanes. The first-eluting diastereomer was used in Step B to produce the more active final product. LC/MS: 501 (M+Na).

後処理

  1. customthe mixture was partitioned between ethyl acetate (25 mL) and saturated aqueous sodium bicarbonate solution (10 mL)
  2. washThe organic layer was washed with saturated aqueous brine (10 mL)
  3. extractionthe aqueous layers were extracted in succession with ethyl acetate (25 mL)
  4. dry with materialThe organic layers were dried over sodium sulfate
  5. customdecanted
  6. customevaporated
  7. customPurification by flash column chromatography (silica gel, 15-20% ethyl aceate/0.75-1.0% methanol/dichloromethane)

出典と根拠

ORDレコード
ord-b40d1eda35024a54b50c82d9de495a01
出典データセット
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07388019B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート